Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.36 |
| ▸ | TNKS | O95271 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12777856 | 0.85 | L3MBTL1 (0.41) | L3MBTL1HTR2CNUDT1 | |
| SCHEMBL12778116 | 0.80 | L3MBTL1 (0.39) | L3MBTL1HTR2CNUDT1 | |
| SCHEMBL103894 | 0.80 | HTR2C (0.53) | L3MBTL1HTR2CNUDT1TNKS | |
| SCHEMBL24387465 | 0.77 | L3MBTL1 (0.37) | L3MBTL1HTR2CNUDT1TNKS | |
| SCHEMBL11261436 | 0.77 | L3MBTL1 (0.44) | L3MBTL1HTR2CNUDT1TNKS | |
| SCHEMBL14538474 | 0.77 | L3MBTL1 (0.44) | L3MBTL1HTR2CNUDT1TNKS | |
| SCHEMBL18248770 | 0.77 | L3MBTL1 (0.53) | L3MBTL1HTR2CNUDT1TNKS | |
| SCHEMBL25987094 | 0.77 | L3MBTL1 (0.41) | L3MBTL1HTR2CNUDT1 | |
| SCHEMBL12778120 | 0.73 | L3MBTL1 (0.41) | L3MBTL1HTR2CNUDT1TNKS | |
| SCHEMBL12777922 | 0.73 | L3MBTL1 (0.33) | L3MBTL1HTR2CNUDT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3553065-A1 | HETEROCYCLIC COMPOUND AS SYK INHIBITOR AND/OR SYK-HDAC DUAL INHIBITOR | Hangzhou Innogate Pharma Co., Ltd. (CN) | 2019-10-16 | — | — | EP | disclosed |